Jolanta Widén

Suggest Changes
Learn More
BACKGROUND The ultrarapid metabolizer phenotype of the cytochrome P4502D6 (CYP2D6) enzyme has been considered a relevant cause of nonresponse to antidepressant drug therapy. Prescribing high doses of(More)
  • 1